by TrN2016_SandWich | Apr 12, 2016
Andrew Charles Andrew has more than 25 years experience in the pharmaceutical industry across all phases of drug discovery from early target identification and validation to late PhIIb. During his career in AstraZeneca, Andrew has worked as a bioscientist in several...
by TrN2016_SandWich | Apr 12, 2016
Charles Phillips Charles has extensive experience in medical leadership of face to face meetings with regulators in the US, UK, Canada and Australia. Providing the clinical overview for registration filings of a biologic product, Type II variations on existing...
